HPV-16 vaccine (V501-005)

Human papillomavirus type 16 vaccine · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HPV-16 vaccine (V501-005), covering 2010-04-09 to 2010-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005) [Phase 2]

See pricing